To further validate the restored angiogenic capacity of D‐ADSCs through GLO1 overexpression, we established a diabetic hindlimb ischemia mice model and intramuscularly injected the ischemic hindlimbs with PBS, D‐ADSCs, G‐D‐ADSCs, or ND‐ADSCs (5 × 106 cells, 100 μL; n = 6) postoperatively. Here, GLO1 is linked to ischemia.